A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes
Clinical trial NCT07112872 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07112872
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-19
- Primary completion
- 2026-11-27
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.